TCHIBANGA, GABON — April 19, 2026 The Nyanga region of Gabon has been the backdrop for a festive and cultural celebration, marking the honor of Dr. Ghyslain Mombo Ngoma, a renowned figure in tropical medicine. His achievement of being listed in the prestigious TIME100 Health list for 2026 has been celebrated by his hometown community and beyond.
Mombo Ngoma, a physician — researcher at the Centre de Recherches Médicales de Lambaréné (CERMEL), has been instrumental in advancing the treatment of malaria, a significant health concern in sub-Saharan Africa. His groundbreaking work in developing a novel single-dose treatment, the SPAP, has garnered international attention and has been a point of pride for Gabon and the Nyanga region.
The SPAP treatment, which includes a four — drug combination, has shown remarkable effectiveness, offering an improvement in patient adherence over the traditional three-day regimen. This breakthrough has been particularly beneficial in regions like sub-Saharan Africa, where compliance with multiple-dose treatment regimens has been challenging. Celebrations in Migoma, the village where Mombo Ngoma’s research was conducted, reflect the local community’s deep respect for his work.
The representative of the village ressortissants expressed their pride and joy at the global recognition of one of their own. Mombo Ngoma himself was surprised by the celebration, acknowledging the immense support of his family and community.
The TIME100 Health list, which recognizes the most influential individuals in health, underscores the international impact of Mombo Ngoma’s contributions. His achievements stand as a testament to the power of innovation and dedication in tropical medicine.
As the world continues to battle malaria, Dr. Mombo Ngoma’s research and recognition are seen as significant milestones in the ongoing fight against the disease. His work serves as a beacon of hope, demonstrating the transformative potential of medical research in addressing global health challenges.
*Additional reporting by ImNews | Sources consulted: 5*
—
By This original article was produced by the ImNews editorial team
Source: Agpgabon
Source: Redaction
